Profile data is unavailable for this security.
About the company
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is involved in enrolling patients in its randomized double-blind placebo-controlled clinical trial for the treatment of pancreatic cancer. The Company's lead assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X). Ivospemin is a polyamine analog designed to induce polyamine metabolic inhibition (PMI). Flynpovi is a combination of CPP-1X (eflornithine) and sulindac. It has a dual mechanism of action whereby it suppresses the synthesis of new polyamines and increases the export and catabolism of polyamines from the diet and microbiome. Eflornithine is being developed as a single-agent tablet or high-dose powder sachet for several indications, including prevention of gastric cancer, treatment of neuroblastoma and recent onset Type 1 diabetes metastatic castration-resistant prostate cancer, and STK-11 mutant NSCLC.
- Revenue in USD (TTM)0.00
- Net income in USD-27.26m
- Incorporated2011
- Employees7.00
- LocationPanbela Therapeutics Inc712 Vista Blvd # 305WACONIA 55387United StatesUSA
- Phone+1 (952) 479-1196
- Websitehttps://panbela.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENDRA Life Sciences Inc | 0.00 | -9.89m | 1.78m | 21.00 | -- | 0.3058 | -- | -- | -1.26 | -1.26 | 0.00 | 0.3388 | 0.00 | -- | -- | 0.00 | -168.89 | -132.00 | -228.29 | -157.28 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 23.67 | -- | -19.46 | -- |
Hi-Great Group Holding Co | 101.27k | -113.56k | 1.78m | -- | -- | -- | -- | 17.58 | -0.0011 | -0.0011 | 0.001 | -0.0011 | 0.7887 | 0.8027 | -- | -- | -88.44 | -- | -- | -- | 48.60 | -- | -112.14 | -- | 0.0197 | -48.81 | -- | -- | -47.32 | -- | -3,789.70 | -- | -- | -- |
Windtree Therapeutics Inc | 0.00 | -5.96m | 1.83m | 15.00 | 0.1673 | 0.1026 | -- | -- | 18.53 | 18.53 | 0.00 | 30.23 | 0.00 | -- | -- | 0.00 | -18.26 | -44.51 | -20.72 | -48.38 | -- | -- | -- | -94,533.34 | -- | -- | 0.00 | -- | -- | -- | 48.25 | -- | -- | -- |
SYBLEU Inc | 11.70k | -307.88k | 1.84m | -- | -- | -- | -- | 157.17 | -0.0293 | -0.0293 | 0.0011 | -0.0367 | 0.0641 | -- | -- | -- | -168.63 | -- | -- | -- | -- | -- | -2,631.45 | -- | -- | -8.48 | 4.96 | -- | 0.00 | -- | 26.51 | -- | -- | -- |
Virpax Pharmaceuticals Inc | 0.00 | -16.89m | 1.88m | 7.00 | -- | -- | -- | -- | -14.42 | -14.42 | 0.00 | -1.04 | 0.00 | -- | -- | 0.00 | -156.21 | -87.52 | -241.52 | -116.56 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 29.84 | -- | -- | -- |
InMed Pharmaceuticals Inc | 5.63m | -6.08m | 1.89m | 13.00 | -- | 0.1295 | -- | 0.3368 | -1.23 | -1.23 | 0.9284 | 1.75 | 0.4006 | 2.71 | 29.77 | -- | -43.26 | -88.10 | -50.03 | -104.19 | 39.20 | -- | -108.01 | -1,066.11 | 5.80 | -- | 0.00 | -- | 279.60 | -- | 57.27 | -- | 29.56 | -- |
Panbela Therapeutics Inc | 0.00 | -27.26m | 1.99m | 7.00 | -- | -- | -- | -- | -20.38 | -20.38 | 0.00 | -0.6563 | 0.00 | -- | -- | 0.00 | -201.94 | -215.89 | -809.38 | -476.38 | -- | -- | -- | -- | -- | -161.79 | 4.16 | -- | -- | -- | 27.68 | -- | -- | -- |
Salarius Pharmaceuticals Inc | 0.00 | -8.92m | 2.02m | 2.00 | -- | 0.4997 | -- | -- | -2.71 | -2.71 | 0.00 | 0.8459 | 0.00 | -- | -- | 0.00 | -119.38 | -69.27 | -193.68 | -79.89 | -- | -- | -- | -675.70 | -- | -- | 0.031 | -- | -- | -- | 60.32 | -- | -- | -- |
PaxMedica Inc | 0.00 | -18.15m | 2.02m | 6.00 | -- | 1.63 | -- | -- | -11.19 | -11.19 | 0.00 | 0.1594 | 0.00 | -- | -- | 0.00 | -474.77 | -755.77 | -781.78 | -- | -- | -- | -- | -- | -- | -3,015.03 | 0.00 | -- | -- | -- | -23.56 | -- | -- | -- |
Procyon Corp | 4.77m | -387.79k | 2.05m | 17.00 | -- | 0.9674 | -- | 0.4301 | -0.0478 | -0.0478 | 0.5891 | 0.2774 | 1.39 | 1.94 | 9.60 | 280,817.70 | -10.81 | 3.52 | -13.69 | 4.23 | 78.01 | 73.30 | -7.78 | 2.52 | 2.22 | -- | 0.00 | -- | -3.22 | 3.11 | 70.44 | -- | 30.98 | -- |
CYANOTECH CORP | 22.49m | -4.62m | 2.08m | 86.00 | -- | 0.1494 | -- | 0.0926 | -0.7265 | -0.7265 | 3.53 | 2.01 | 0.7889 | 1.53 | 10.73 | 261,546.50 | -16.19 | -2.32 | -21.07 | -2.96 | 29.59 | 35.88 | -20.52 | -2.33 | 0.3702 | -5.93 | 0.3299 | -- | -35.56 | -7.44 | -259.70 | -- | 1.22 | -- |
Galmed Pharmaceuticals Ltd | 0.00 | -6.36m | 2.12m | 3.00 | -- | 0.1567 | -- | -- | -2.83 | -2.83 | 0.00 | 2.12 | 0.00 | -- | -- | 0.00 | -43.37 | -45.06 | -51.38 | -50.79 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.31 | -- | -- | -- |
AgriFORCE Growing Systems Ltd | 16.28k | -13.34m | 2.13m | 7.00 | -- | 0.2068 | -- | 130.98 | -10.78 | -10.78 | 0.0039 | 0.396 | 0.0009 | -- | 0.443 | 2,325.71 | -74.39 | -78.95 | -100.77 | -109.86 | 16.58 | -- | -81,946.25 | -243,182.50 | 0.8186 | -1.30 | 0.1913 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
American Green Inc | -100.00bn | -100.00bn | 2.14m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Woodbury Financial Services, Inc.as of 31 Dec 2023 | 4.00 | 0.00% |
Tower Research Capital LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Citadel Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Two Sigma Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
HRT Financial LLCas of 31 Mar 2024 | 0.00 | 0.00% |